Date: 2015-01-08
Type of information: Company acquisition
Acquired company: Atreus Pharmaceuticals (Canada)
Acquiring company: Advanced Accelerator Applications (France)
Amount: undisclosed
Terms: * On January 8, 2015, Advanced Accelerator Applications, an international specialist in Molecular Nuclear Medicine (MNM), announced that it has acquired the remaining 49.9% of Atreus Pharmaceuticals Corporation, a development-stage biopharmaceutical company headquartered in Ottawa, Canada and focused on the development of proprietary molecular imaging products aimed at imaging apoptosis and necrosis based on Annexin V. Atreus Pharmaceuticals Corporation is now a fully owned AAA subsidiary and has been renamed AAA Canada.
Details:
Related: Nuclear medicine
